Homebiotech

biotech

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Lab-engineered proteins: a promising treatment for liver disease

Jim Cornall - June 24, 2026

biotech

XtalPi and DoveTree launch $6bn AI drug discovery collaboration

Jim Cornall - August 13, 2025

biotech

Anbio Biotechnology develops Chikungunya rapid test

Jim Cornall - August 13, 2025

biotech

AMI Pharm advances fat-reduction injectable drug to phase 3

Jim Cornall - August 13, 2025

biotech

AI+CRISPR=Precise gene editing

Jim Cornall - August 12, 2025

biotech

AXA signs agreement with Hainan Boao Lecheng Administration

Jim Cornall - August 12, 2025

biotech

ProBio launches AAV manufacturing service

Jim Cornall - August 12, 2025

biotech

Altasciences and VoxCell BioInnovation to collaborate on preclinical drug development

Jim Cornall - August 11, 2025

AI

KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations

admin - August 11, 2025

1...676869...85 Page 68 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026 0

Memento Medicines, Inc., a privately-held biotech company developing biologic therapies for retinal diseases, has complete a $93m Series A financing round co-led by Forbion,...

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0

Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal

biotech Jim Cornall - June 24, 2026 0